Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition

References

• Binder MR. Gabapentin—the popular but controversial anticonvulsant drug may be zeroing in on the pathophysiology of disease. AJCEM. 2021;9(4):122–134. doi:10.11648/j.ajcem.20210904.15
   Google Scholar
• Zullino DF, Khazaal Y, Hattenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today. 2004;40(7):603–620. doi:10.1358/dot.2004.40.7.850478
   PubMed Web of Science ®Google Scholar
• Ostadhadi S, Akbarian R, Norouzi-Javidan A, et al. Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effects of gabapentin in mouse forced swimming test. Can J Physiol Pharmacol. 2017;95(7):795–802. doi:10.1139/cjpp-2016-0292
   PubMed Web of Science ®Google Scholar
• Ostadhadi S, Kordjazy N, Haj-Mirzaian A, Ameli S, Akhlaghipour G, Dehpour A. Involvement of NO/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test. Naunyn-Schmiedebergs Archiv Pharmacol. 2016;389:393–402. doi:10.1007/s00210-015-1203-5
   PubMed Web of Science ®Google Scholar
• Evoy KE, Peckham AM, Covvey JR, Tidgewell KJ. Gabapentinoid pharmacology in the context of emerging misuse liability. J Clin Pharmacol. 2021;61:S89–S99. doi:10.1002/jcph.1833
   PubMed Web of Science ®Google Scholar
• Rao ML, Clarenbach P, Vahlensieck M, Krätzschmar S. Gabapentin augments whole blood serotonin in healthy young men. J Neural Transm. 1988;73:129–134. doi:10.1007/BF01243384
   PubMed Web of Science ®Google Scholar
• Kapil V, Green JL, Le Lait M-C, Wood DM, Dargan PI. Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in the UK. Br J Clin Pharmacol. 2014;78(1):190. doi:10.1111/bcp.12277
   PubMed Web of Science ®Google Scholar
• Khave LJ, Noori M, Rahimi-Movaghar A, Noroozi A. Management of gabapentin misuse in a patient with previous history of opioid use disorder: case report. Asian J Psychiatr. 2023;80:103322. doi:10.1016/j.ajp.2022.103322
   PubMed Web of Science ®Google Scholar
• Venkatesh G, Kalaiyarasi C, Ramanathan M. Antidepressant like effect of gabapentin decreases the immobility time in despair animal models in mice: roll of serotonergic system in it. Res J Pharma Technol. 2011;4(11):1702–1706.
   Google Scholar
• Türk S, Tok F, Erdoğan Ö, et al. Synthesis, anticancer evaluation and in silico ADMET studies on urea/thiourea derivatives from gabapentin. Phosphorus Sulfur Silicon Relat Elem. 2020;196(4):382–388. doi:10.1080/10426507.2020.1845678
   Web of Science ®Google Scholar
• Saleem MF, Khan MA, Ahmad I, Aslam N, Khurshid U. Synthesis and characterization of some new Schiff base derivatives of gabapentin, and assessment of their antibacterial, antioxidant and anticonvulsant activities. Trop J Pharma Res. 2021;20(1):145–153. doi:10.4314/tjpr.v20i1.21
   Web of Science ®Google Scholar
• Ahmad N, Subhan F, Islam NU, et al. Pharmacological evaluation of the gabapentin salicylaldehyde derivative, gabapentsal, against tonic and phasic pain models, inflammation, and pyrexia. Naunyn-Schmiedebergs Archiv Pharmacol. 2021;394:2033–2047. doi:10.1007/s00210-021-02118-x
   PubMed Web of Science ®Google Scholar
• Kanwal N, Khan IU, Sharif S, Hussain EA, Mehmood A, Sahin O. Efficient syntheses, crystal structure and thermal properties of gabapentin 4-acetamido, 2-mesitylene and 2, 4-dinitro sulfonamides derivatives. J Chem Crystallogr. 2019;49:162–168. doi:10.1007/s10870-018-00765-2
   Web of Science ®Google Scholar
• Papagiouvannis G, Theodosis-Nobelos P, Tziona P, Gavalas A, Kourounakis PN, Rekka EA. Gabapentin antioxidant derivatives with anti-inflammatory and neuroprotective potency. Lett Drug Des Discov. 2022;19(7):579–590. doi:10.2174/1570180818666211210161922
   Web of Science ®Google Scholar
• Dingman MA, Gyekis JP, Whetzel CA, Klein LC, Vandenbergh DJ. Age-specific locomotor response to nicotine in yellow and mottled yellow A vy/a mice. BMC Res Notes. 2013;6(1):497. doi:10.1186/1756-0500-6-497
   PubMedGoogle Scholar
• Hall CS. Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality. J Comp Psychol. 1934;18(3):385. doi:10.1037/h0071444
   Google Scholar
• Lezak KR, Missig G, Carlezon WA. Behavioral methods to study anxiety in rodents. Dialogues Clin Neurosci. 2022;2022:154.
   Google Scholar
• Arif M, Rauf K, Rehman NU, Tokhi A, Ikram M, Sewell RD. 6-methoxyflavone and donepezil behavioral plus neurochemical correlates in reversing chronic ethanol and withdrawal induced cognitive impairment. Drug Des Devel Ther. 2022;1573–1593. doi:10.2147/DDDT.S360677
   PubMed Web of Science ®Google Scholar
• Rehman NU, Abbas M, Al-Rashida M, et al. Effect of 4-fluoro-N-(4-sulfamoylbenzyl) benzene sulfonamide on acquisition and expression of nicotine-induced behavioral sensitization and striatal adenosine levels. Drug Des Devel Ther. 2020;14:3777. doi:10.2147/DDDT.S270025
   PubMed Web of Science ®Google Scholar
• Walia V, Garg C, Garg M. NO-sGC-cGMP signaling influence the anxiolytic like effect of lithium in mice in light and dark box and elevated plus maze. Brain Res. 2019;1704:114–126. doi:10.1016/j.brainres.2018.10.002
   PubMed Web of Science ®Google Scholar
• Bertagna NB, Dos Santos PGC, Queiroz RM, Fernandes GJD, Cruz FC, Miguel TT. Involvement of the ventral, but not dorsal, hippocampus in anxiety-like behaviors in mice exposed to the elevated plus maze: participation of CRF1 receptor and PKA pathway. Pharmacol Rep. 2021;73(1):57–72. doi:10.1007/s43440-020-00182-3
   PubMed Web of Science ®Google Scholar
• Mayorga AJ, Dalvi A, Page ME, Zimov-Levinson S, Hen R, Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor mutant mice. J Pharmacol Exp Therap. 2001;298(3):1101–1107.
   PubMed Web of Science ®Google Scholar
• Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology. 1985;85(3):367–370. doi:10.1007/BF00428203
   PubMed Web of Science ®Google Scholar
• Vadnie CA, DePoy LM, McClung CA. Measuring the effects of circadian rhythm-related manipulations on depression-like behavior in rodents: forced swim and tail suspension tests. In: Circadian Clocks. Springer; 2021:69–78.
   Google Scholar
• Perez E, De Biasi M. Assessment of affective and somatic signs of ethanol withdrawal in C57BL/6J mice using a short-term ethanol treatment. Alcohol. 2015;49(3):237–243. doi:10.1016/j.alcohol.2015.02.003
   PubMed Web of Science ®Google Scholar
• Abi I, Ashiekaa M, Abi E, Adeniyi OS, Saalu LC. High fat diet alteration of gut microbiota impacts learning, memory and anxiety response in mice: cannabidiol and omega 3 possible remedies. Adv Alzheimers Dis. 2022;11(1):1–9. doi:10.4236/aad.2022.111001
   Google Scholar
• Prieur EA, Jadavji NM. Assessing spatial working memory using the spontaneous alternation Y-maze test in aged male mice. Bio-Protocol. 2019;9(3). doi:10.21769/BioProtoc.3162
   PubMed Web of Science ®Google Scholar
• Rauf K, Subhan F, Sewell RD. A bacoside containing Bacopa monnieri extract reduces both morphine hyperactivity plus the elevated striatal dopamine and serotonin turnover. Phytother Res. 2012;26(5):758–763. doi:10.1002/ptr.3631
   PubMed Web of Science ®Google Scholar
• Martin JC, Gainer D. Psychiatric uses of gabapentin. Innov Clin Neurosci. 2022;19(7–9):55–60.
   PubMedGoogle Scholar
• Berlin RK, Butler PM, Perloff MD. Gabapentin therapy in psychiatric disorders: a systematic review. Prim Care Companion CNS Disord. 2015;17(5):27293.
   Google Scholar
• Yasmin S, Carpenter LL, Leon Z, Siniscalchi JM, Price LH. Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review. J Affect Disord. 2001;63(1–3):243–247. doi:10.1016/S0165-0327(00)00187-7
   PubMed Web of Science ®Google Scholar
• Oka M, Itoh Y, Wada M, Yamamoto A, Fujita T. Gabapentin blocks L-type and P/Q-type Ca 2+ channels involved in depolarization-stimulated nitric oxide synthase activity in primary cultures of neurons from mouse cerebral cortex. Pharm Res. 2003;20:897–899. doi:10.1023/A:1024078704020
   PubMed Web of Science ®Google Scholar
• Oka M, Itoh Y, Wada M, Yamamoto A, Fujita T. A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices. Br J Pharmacol. 2003;139(2):435–443. doi:10.1038/sj.bjp.0705246
   PubMed Web of Science ®Google Scholar
• Rajasekaran K, Jayakumar R, Venkatachalam K. Increased neuronal nitric oxide synthase (nNOS) activity triggers picrotoxin-induced seizures in rats and evidence for participation of nNOS mechanism in the action of antiepileptic drugs. Brain Res. 2003;979(1–2):85–97. doi:10.1016/S0006-8993(03)02878-6
   PubMed Web of Science ®Google Scholar
• Bang S, Yoo S, Hwang SW. Gabapentin attenuates the activation of transient receptor potential A1 by cinnamaldehyde. Exp Neurobiol. 2009;18(1):1–7. doi:10.5607/en.2009.18.1.1
   Google Scholar
• Kukkar A, Bali A, Singh N, Jaggi AS. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res. 2013;36:237–251. doi:10.1007/s12272-013-0057-y
   PubMed Web of Science ®Google Scholar
• Bergquist F, Jonason J, Pileblad E, Nissbrandt H. Effects of local administration of L‐, N‐, and P/Q‐type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat. J Neurochem. 1998;70(4):1532–1540. doi:10.1046/j.1471-4159.1998.70041532.x
   PubMed Web of Science ®Google Scholar
• Fass DM. Regulation of L-Type Calcium (2+) Channels in Pituitary Cells. University of Pittsburgh; 1999.
   Google Scholar
• Guiard BP, Mansari ME, Blier P. Prospect of a dopamine contribution in the next generation of antidepressant drugs: the triple reuptake inhibitors. Curr Drug Targets. 2009;10(11):1069–1084. doi:10.2174/138945009789735156
   PubMed Web of Science ®Google Scholar
• Prica C, Hascoet M, Bourin M. Is co-administration of bupropion with SSRIs and SNRIs in forced swimming test in mice, predictive of efficacy in resistant depression? Behav Brain Res. 2008;194(1):92–99. doi:10.1016/j.bbr.2008.06.028
   PubMed Web of Science ®Google Scholar
• Yamada J, Sugimoto Y, Yamada S. Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur J Pharmacol. 2004;504(3):207–211. doi:10.1016/j.ejphar.2004.09.057
   PubMed Web of Science ®Google Scholar
• Lambert G, Johansson M, Ågren H, Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness: evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry. 2000;57(8):787–793. doi:10.1001/archpsyc.57.8.787
   PubMed Web of Science ®Google Scholar
• Terbeck S, Savulescu J, Chesterman LP, Cowen PJ. Noradrenaline effects on social behaviour, intergroup relations, and moral decisions. Neurosci Biobehav Rev. 2016;66:54–60. doi:10.1016/j.neubiorev.2016.03.031
   PubMed Web of Science ®Google Scholar
• Mesripour A, Sajadian S, Hajhashemi V. Antidepressant-like effect of vitamin B6 in mice forced swimming test and the possible involvement of the noradrenergic system. J Rep Pharma Sci. 2019;8(2):133. doi:10.4103/jrptps.JRPTPS_52_18
   Google Scholar
• Estrada VB, Matsubara NK, Gomes MV, Corrêa FMA, Pelosi GG. Noradrenaline microinjected into the dorsal periaqueductal gray matter causes anxiolytic-like effects in rats tested in the elevated T-maze. Life Sci. 2016;152:94–98. doi:10.1016/j.lfs.2016.03.011
   PubMed Web of Science ®Google Scholar
• Rantamäki T, Hendolin P, Kankaanpää A, et al. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cγ signaling pathways in mouse brain. Neuropsychopharmacology. 2007;32(10):2152–2162. doi:10.1038/sj.npp.1301345
   PubMed Web of Science ®Google Scholar
• Kozisek ME, Middlemas D, Bylund DB. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther. 2008;117(1):30–51. doi:10.1016/j.pharmthera.2007.07.001
   PubMed Web of Science ®Google Scholar
• Kim IB, Park S-C. Neural circuitry–neurogenesis coupling model of depression. Int J Mol Sci. 2021;22(5):2468. doi:10.3390/ijms22052468
   PubMed Web of Science ®Google Scholar
• Yan Z, Rein B. Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications. Mol Psychiatry. 2022;27(1):445–465. doi:10.1038/s41380-021-01092-3
   PubMed Web of Science ®Google Scholar
• Singh P, Mehdi MM. Functional foods, bioactives, and cognitive impairments during aging. In: Plant Bioactives as Natural Panacea Against Age-Induced Diseases. Elsevier; 2023:271–286.
   Google Scholar
• Sharma K, Sundriyal A, Loshali A, Agrawal M, Krishna CG, Singh Y. Mechanism of action of antidepressants. In: How Synthetic Drugs Work. Elsevier; 2023:255–273.
   Google Scholar
• Eloziia N, Kumar N, Kothiyal P, Deka P, Nayak BK. A review on antidepressant plants. J Pharma Res. 2017;11(5):382–396.
   Google Scholar
• Yardımcı H, Demir G. The relationship of diet quality and body composition with depression level in young women. Acta Scientiarum Health Sci. 2023;45:e60410–e60410. doi:10.4025/actascihealthsci.v45i1.60410
   Google Scholar